EUVIMEDEUVIMED entdecken
Open Access

One-time low concentration betadine eye wash: A novel treatment for epidemic viral conjunctivitis for accelerated recovery

Sumedha Vats, Anchal Tripathi, Inam Danish Khan, Pawan Dhull, Sanjay Kumar Mishra, Ranjit Goenka, Devendra Paul Vats

Romanian Journal of Ophthalmology · 2024

DOI: 10.22336/rjo.2024.49 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Romanian Journal of Ophthalmology, 2024. Verfasst von Sumedha Vats und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Armed Forces Clinic, New Delhi, India. Hauptthemen laut MEDLINE: Povidone-Iodine, Conjunctivitis, Viral, Anti-Infective Agents, Local, Ophthalmic Solutions. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to renew the management of viral epidemic conjunctivitis by introducing a one-time, low-concentration ocular surface povidone-iodine (LOS-pI) wash.

Methods

Among the 3,002 patients screened, 1,328 with acute conjunctivitis were categorized into two groups. Group A (664 patients) underwent a 1% betadine wash in addition to the standard treatment protocol (Eye Lubricant + Moxifloxacin 0.5% eyedrops), while Group B (664 patients) followed the standard protocol alone. In cases of membranous conjunctivitis, manual membrane removal was performed. Treatment responses were observed daily for three days, followed by weekly assessments for two additional weeks.

Results

Co-infection of adenovirus with enterovirus was found to be the main cause, often accompanied by staphylococcal superinfection. Group A showed complete resolution of conjunctival inflammation, with a remarkable 76.05% of patients experiencing improvement within an average of 2.6±0.51 days, in contrast to Group B's average of 7.5±1.1 days (p

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Povidone-IodineConjunctivitis, ViralAnti-Infective Agents, LocalOphthalmic SolutionsHumansFemaleMaleAdultMiddle AgedEye Infections, ViralYoung AdultAdolescentCOVID-19Treatment OutcomeAgedSARS-CoV-2Child

Stichwörter der Autor:innen

adenovirusbetadine washenterovirusepidemic conjunctivitisstaphylococcusviral conjunctivitis

Substanzen

Povidone-IodineAnti-Infective Agents, LocalOphthalmic Solutions

Autor:innen und Institutionen

  • Department of Ophthalmology, Armed Forces Clinic, New Delhi, India.
  • Department of Ophthalmology, Military Hospital, Jammu, India.
  • Department of Clinical Microbiology and Infectious Diseases, Armed Forces Clinic, New Delhi, India.
  • DNB Neurology, Armed Forces Clinic, New Delhi, India.
  • Department of Ophthalmology, Army Hospital Research and Referral, New Delhi, India.
  • Department of Ophthalmology, Base Hospital Delhi Cantt, New Delhi, India.

Zitieren

APA

Vats, S., Tripathi, A., Khan, I. D., Dhull, P., Mishra, S. K., Goenka, R., & Vats, D. P. (2024). One-time low concentration betadine eye wash: A novel treatment for epidemic viral conjunctivitis for accelerated recovery. Romanian Journal of Ophthalmology. https://doi.org/10.22336/rjo.2024.49

Vancouver

Vats S, Tripathi A, Khan ID, Dhull P, Mishra SK, Goenka R, et al. One-time low concentration betadine eye wash: A novel treatment for epidemic viral conjunctivitis for accelerated recovery. Romanian Journal of Ophthalmology. 2024. doi:10.22336/rjo.2024.49

BibTeX
@article{Vats2024,
  author = {Vats, Sumedha and Tripathi, Anchal and Khan, Inam Danish and Dhull, Pawan and Mishra, Sanjay Kumar and Goenka, Ranjit and Vats, Devendra Paul},
  title = {One-time low concentration betadine eye wash: A novel treatment for epidemic viral conjunctivitis for accelerated recovery},
  journal = {Romanian Journal of Ophthalmology},
  year = {2024},
  doi = {10.22336/rjo.2024.49}
}
Kostenlos starten →